Anaesthesiologic Considerations for Intraoperative ECMO Anticoagulation During Lung Transplantation: A Single-Centre, Retrospective, Observational Study
Transplant International · 2024
DOI: 10.3389/ti.2024.12752 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Transplant International, 2024. Verfasst von Jaromir Vajter und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anaesthesiology, Resuscitation, and Intensive Care Medicine, Second Faculty of Medicine, Charles University, University Hospital in Mot…. Hauptthemen laut MEDLINE: Extracorporeal Membrane Oxygenation, Lung Transplantation, Thrombosis. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Extracorporeal membrane oxygenation (ECMO) is frequently used during lung transplantation. Unfractionated heparin (UFH) is mainly used as part of ECMO support for anticoagulation. One of the most common perioperative complications is bleeding, which high-dose UFH can aggravate.
Methods
We retrospectively analyzed ( n = 141) patients who underwent lung transplantation between 2020 and 2022. All subjects ( n = 109) underwent central cannulated VA ECMO with successful intraoperative ECMO weaning. Patients on ECMO bridge, postoperative ECMO, heart-lung transplants and transplants without ECMO were excluded. The dose of UFH for the entire surgical procedure, blood loss and consumption of blood derivatives intraoperatively and 48 h after ICU admission were recorded. Surgical revision for postoperative bleeding were analyzed. Thrombotic complications, mortality and long-term survival were evaluated.
Results
Lower doses of UFH administered for intraoperative ECMO anticoagulation contribute to a reduction in intraoperative blood derivates consumption and blood loss with no thrombotic complications related to the patient or the ECMO circuit. Lower doses of UFH may lead to a decreased incidence of surgical revision for hemothorax.
Conclusion
Lower doses of UFH as part of intraoperative ECMO anticoagulation might reduce the incidence of complications and lead to better postoperative outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anaesthesiology, Resuscitation, and Intensive Care Medicine, Second Faculty of Medicine, Charles University, University Hospital in Motol, Prague, Czechia.
- Prague Lung Transplant Program, 3rd Department of Surgery, First Faculty of Medicine, Charles University, University Hospital in Motol, Prague, Czechia.
Zitieren
APA
Vajter, J., Holubova, G., Novysedlak, R., Svorcova, M., Vachtenheim, J., Vymazal, T., & Lischke, R. (2024). Anaesthesiologic Considerations for Intraoperative ECMO Anticoagulation During Lung Transplantation: A Single-Centre, Retrospective, Observational Study. Transplant International. https://doi.org/10.3389/ti.2024.12752
Vancouver
Vajter J, Holubova G, Novysedlak R, Svorcova M, Vachtenheim J, Vymazal T, et al. Anaesthesiologic Considerations for Intraoperative ECMO Anticoagulation During Lung Transplantation: A Single-Centre, Retrospective, Observational Study. Transplant International. 2024. doi:10.3389/ti.2024.12752
BibTeX
@article{Vajter2024,
author = {Vajter, Jaromir and Holubova, Gabriela and Novysedlak, Rene and Svorcova, Monika and Vachtenheim, Jiri and Vymazal, Tomas and Lischke, Robert},
title = {Anaesthesiologic Considerations for Intraoperative ECMO Anticoagulation During Lung Transplantation: A Single-Centre, Retrospective, Observational Study},
journal = {Transplant International},
year = {2024},
doi = {10.3389/ti.2024.12752}
}
EUVIMED